RecruitingNCT07007156
Is a Positive NECPAL in ICU Patients Associated With Higher Mortality
Sponsor
Consorci Sanitari de l'Alt Penedès i Garraf
Enrollment
199 participants
Start Date
Jun 12, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of the present study is to evaluate the usefulness of the NECPAL scale in identifying Intensive Care Unit (ICU)-admitted patients at higher risk of dying within 90 days of ICU admission
Eligibility
Min Age: 75 Years
Inclusion Criteria4
- Men and women aged 75 years or older.
- Admission to the ICU of the study center.
- Legal capacity to provide informed consent.
- Signed informed consent for study inclusion, either by the participant or their legal representative.
Exclusion Criteria1
- Death within the first 24 hours of ICU admission.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNECPAL positive
This group has a positive result for NECPAL scale
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07007156
Related Trials
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
NCT069492281 location
Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU)
NCT066553371 location
Evaluation of a Residential In-Reach Program in Regional and Rural Australia
NCT069011678 locations
A Long-term Observational Study to Describe the Use of Vitamin-C Injektopas® 7.5 g in Patients With Vitamin C Deficiency
NCT069838471 location
Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
NCT046150651 location